Promoter hypermethylation is an important pathway for repression of gene transcription in
cancer cells and a promising marker for cancer detection. We tested five gene promoters […

Introduction Hepatotoxicity from T-cell checkpoint blockade is an increasingly common
immune-related adverse event, but remains poorly characterised and can be challenging to …

Purpose : Hypermethylation of the glutathione S-transferase gene (GSTP1) is the most
common (greater than 90%) reported epigenetic alteration in prostate cancer. It occurs early in …

Background and purpose A variety of radiotherapy fractionations are used as potentially
curative treatments for non-small cell lung cancer. In the UK, 55 Gy in 20 fractions over 4 weeks (…

Hypermethylation of the 5′ promoter region of the glutathione S-transferase π gene (GSTP1)
occurs at a very high frequency in prostate adenocarcinoma. We compared the results of …

Purpose To report toxicity and early survival data for IDEAL-CRT, a trial of dose-escalated
concurrent chemoradiotherapy (CRT) for non-small cell lung cancer. Patients and Methods …

Purpose Not all patients with stage III non-small cell lung cancer (NSCLC) are suitable for
concurrent chemoradiation therapy (CRT). Local failure rate is high for sequential concurrent …

Quality Indicators, based on clinical practice guidelines, have been used in medicine and
within oncology to measure quality of care for over twenty years. However, radiation oncology …

Purpose: In this study, we tested the ability of a panel of hypermethylation markers to
improve the sensitivity of histologic prostate cancer detection in sextant needle biopsies. …

Introduction Optimal management of people with advanced NSCLC depends on accurate
identification of predictive markers. Yet, real-world data in this setting are limited. We describe …